Article
Presence of the 5,10-methylenetetrahydrofolate reductase C677T mutation in Puerto Rican patients with neural tube defects.
Journal of child neurology - 1 Jan 2002
García-Fragoso Lourdes, García-García Inés, de la Vega Alberto, Renta Jessicca, Cadilla Carmen L
Abstract excerpt
Folic acid supplementation can reduce the incidence of neural tube defects. The first reported genetic risk factor for neural tube defects is a C677T mutation in the 5,10-methylenetetrahydrofolate reductase gene, resulting in decreased activity of the enzyme. We examined the enzyme mutation role of methylenetetrahydrofolate reductase in the etiology of neural tube defects in our population. The study group...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
